Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: An exemplary server cabinet includes two brackets defining a space therebetween for receiving servers, and two guiding fixtures respectively engaged with the two brackets. Each bracket defines a latching hole. Each guiding fixture includes a supporting member and a latching member. The supporting member includes a main plate and a supporting arm extending from the main plate towards the space. The latching member includes a resisting plate attached to the main plate and a pivot extending from the resisting plate. A plurality of protrusions extends outwards from an end of the pivot. The latching member is rotated to engage the protrusions with the corresponding bracket at a periphery of the latching hole after the end of the pivot extends through the supporting member and the latching hole of the bracket such that the main plate is sandwiched between the resisting plate and the bracket and attached to the bracket.

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: A mounting bracket includes a bottom panel and two guiding rails disposed on the bottom panel. The extending direction of the two guiding rails is parallel to a sliding direction of a server. The two guiding rails is configured to guide the server to slide in the mounting bracket along the sliding direction.

Abstract: A system and computer usable code is provided for using a templated pattern to define part types on a web service definition language (WSDL) interface. Applying the templated pattern enables peer services to define a transparent contract between specific WSDL part types. The templated pattern is used to wrap the original business object with the enriched business graph schema. The templated business graph is created by extending the business graph complex type that is provided by the business object framework runtime and adding an element delegating to the original business object.

Abstract: An exemplary rack enclosure includes a frame, and two opposite first brackets and two opposite second brackets mounted on the frame in parallel for securing an electronic device thereon. Each of the first brackets includes a mounting plate secured on the frame and parallel and spaced abutting sheets extending from a side of the mounting plate for supporting an end of the electronic device.

Abstract: A rack enclosure includes a cuboid frame, and two opposite first brackets and two opposite second brackets mounted on the frame for securing an electronic device thereon. Each of the first brackets includes a mounting plate secured on the frame and a guide portion distorting angularly from a side of the mounting plate along a direction away from an opposite side of the mounting plate for guiding an end of the electronic device. The guide portion includes a connecting plate connecting with the mounting plate and a guide plate distorting angularly from the connecting plate along the direction away the opposite side of the mounting plate. An angle defined between the guide plate and the connecting plate is not smaller than 90 degrees.

Abstract: The invention comprises substituted diazaindole-dicarbonyl-piperazinyl derivatives of general Formula I wherein: Q is selected from the group consisting of -- may represent a bond; T is —C(O)— or —CH(CN)—; and —Y— is selected from the group consisting of compositions thereof and their use for treating HIV infection.

Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: A method of electronically monitoring a subject, for example in a home care environment, to determine the presence of the subject in zones of the environment as a function of time includes fusing data from image and wearable sensors. A grid display for displaying the presence in the zones is also provided.

Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

Abstract: A method and system for rendering a captured image of a scene is disclosed which provide see-through vision through the rendered image, for example of an augmented reality object rendered behind the scene, by assigning pixel transparency values in dependence upon captured image pixels. The method and system preserve some structure of the scene in the rendered image without requiring a model of the scene.

Abstract: Disclosed is a method of preparing a personal care composition, comprising the steps: (1) preparing a hot oil phase comprising the surfactant and the high melting point fatty compound; (2) preparing a cold aqueous phase comprising the aqueous carrier; and (3) mixing the oil phase and the aqueous phase to form an emulsion; wherein the mixing step (3) comprises the following detailed steps: (3-1) feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0×102 J/m3 or more; (3-2) feeding the other phase directly to the field; and (3-3) forming an emulsion. The method further requires that the mixing step (3) is conducted by using a homogenizer having a rotating member.

Abstract: Disclosed is a method of preparing a personal care composition, comprising the steps: (1) preparing a hot oil phase comprising the surfactant and the high melting point fatty compound; (2) preparing a cold aqueous phase comprising the aqueous carrier; and (3) mixing the oil phase and the aqueous phase to form an emulsion; wherein the mixing step (3) comprises the following detailed steps: (3-1) feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0×102 J/m3 or more; (3-2) feeding the other phase directly to the field; and (3-3) forming an emulsion. The method further requires that the surfactant is mono-alkyl cationic surfactant and the composition is substantially free of di-alkyl cationic surfactants.

Abstract: Disclosed is a method of preparing a personal care composition, comprising the steps: (1) preparing a hot oil phase comprising the surfactant and the high melting point fatty compound; (2) preparing a cold aqueous phase comprising the aqueous carrier; and (3) mixing the oil phase and the aqueous phase to form an emulsion; wherein the mixing step (3) comprises the following steps: (3-1) feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0×102 J/m3 or more; (3-2) feeding the other phase directly to the field; and (3-3) forming an emulsion. The method further requires that: mixing step (3) is conducted using a homogenizer having a rotating member; surfactant is mono-alkyl cationic surfactant and composition is substantially free of di-alkyl cationic surfactants; and oil phase contains from 0 to 50% of an aqueous carrier by weight of the oil phase.